Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Treatment Burden and Chronic Illness: Who is at Most Risk?
Dimethyl fumarate protection against collagen II degradation.
FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Neuro-Immune Interactions at Barrier Surfaces.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Preclinical studies of sex differences: a clinical perspective.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE))
CombiRx for MS not better than monotherapy
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.

Pages